Campion Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Campion Asset Management's LLY Position: Q1 2026 in Review
Campion Asset Management reduced its Eli Lilly (LLY) stake by 5.9% in Q1 2026, selling an estimated $172K and leaving 2,732 shares worth $2.51M. The position accounts for 1.7% of the portfolio, ranked #16.
Campion Asset Management first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.12M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Campion Asset Management held 2,732 shares of Eli Lilly worth $2.51M as of Q1 2026.
- Campion Asset Management sold 170 Eli Lilly shares in Q1 2026, an estimated $172K.
- Eli Lilly made up 1.7% of Campion Asset Management's portfolio in Q1 2026, its #16 holding.
- Campion Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
- Campion Asset Management's Eli Lilly position peaked at $3.12M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Campion Asset Management's 13F filing for Q1 2026, filed 14 May 2026.